3

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: June 23, 2017
Period of Report: May 18, 2017
Accession Number: 0001078782-17-000909

View Document ↗ View on SEC.gov ↗